Zobrazeno 1 - 10
of 134
pro vyhledávání: '"ahmet sezer"'
Autor:
James C. Coons, Jennifer Kliner, Michael A. Mathier, Suresh Mulukutla, Floyd Thoma, Ahmet Sezer, Mary Keebler
Publikováno v:
American Heart Journal Plus, Vol 47, Iss , Pp 100470- (2024)
Study objective: To evaluate the impact of a medication optimization clinic (MOC) on GDMT and outcomes for patients with HFrEF versus usual care. Design: Retrospective evaluation of a multi-site MOC was conducted. Setting: Large health system with ac
Externí odkaz:
https://doaj.org/article/b7a764e0ef3140cd83b4ef9f45fc90dd
Autor:
Merve Mısırlıoğlu, Ahmet Sezer, Dinçer Yıldızdaş, Özden Özgür Horoz, Faruk Ekinci, Selcan Türker Çolak, Dilek Özcan
Publikováno v:
Journal of Pediatric Emergency and Intensive Care Medicine, Vol 10, Iss 3, Pp 212-215 (2023)
Distal intestinal obstruction syndrome (DIOS), also defined as the equivalent of meconium ileus, is a sign of complete or partial ileocecal obstruction with intestinal contents in patients with cystic fibrosis. DIOS may occur because of darkened inte
Externí odkaz:
https://doaj.org/article/117b83d668044d3d802e2a3e3cbc521c
Autor:
Özgür Özyilkan, Haldun Müderrisoğlu, Şenol Demırcan, Ahmet Sezer, Ahmet Sümbül, Ayşenur Uçar, Aynur Acıbuca
Publikováno v:
Sakarya Tıp Dergisi, Vol 13, Iss 2, Pp 314-320 (2023)
Pertuzumab-mediated Cardiotoxicity: A Single Center Study. Objective: Recent clinical trials have shown that adding pertuzumab to trastuzumab improved the cellular response to therapy and provides a survival benefit compared with trastuzumab alone. H
Externí odkaz:
https://doaj.org/article/eeef385ba7334de88aad398973d69d8d
Autor:
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kilickap
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Introduction The advances in immune checkpoint inhibitors (ICIs) were relatively slow in rare tumors. Therefore, we conducted a multi‐center study evaluating the efficacy of ICI monotherapy and the combination of ICIs with chemotherapy (CT
Externí odkaz:
https://doaj.org/article/0f697c742e7245d3a185d956a2ca5f1a
Autor:
Mustafa Ozguroglu, Saadettin Kilickap, Igor Bondarenko, Ahmet Sezer, Mahmut Gümüş, Miranda Gogishvili, Xuanyao He, Giuseppe Gullo, Petra Rietschel, Ruben GW Quek
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d567674c409344d1a377a09a1890d0a4
Autor:
Mehak Dhande, Amr Barakat, Ann Canterbury, Floyd Thoma, Suresh Mulukutla, Ahmet Sezer, Konstantinos N. Aronis, Aditya Bhonsale, Krishna Kancharla, Andrew H. Voigt, Norman C. Wang, Alaa Shalaby, N. A. Mark Estes, Samir Saba, Sandeep K. Jain
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 18 (2023)
Background Over the next few years, atrial fibrillation (AF)–related morbidity and costs will increase significantly. Thus, it is prudent to examine the impact of AF treatment on health care resource use. This study examined the impact of AF ablati
Externí odkaz:
https://doaj.org/article/4049c6e3a57d41e8b1f04ff1d6fd0305
Autor:
Aynur Acibuca, Ahmet Sezer, Mustafa Yilmaz, Ahmet Taner Sumbul, Senol Demircan, Ibrahim Haldun Muderrisoglu, Ozgur Ozyilkan
Publikováno v:
Journal of International Medical Research, Vol 49 (2021)
Objective New anti-cancer drugs promise to increased survival benefits and reduce adverse events. Trastuzumab emtansine (T-DM1) is a novel anti-human epidermal growth factor receptor 2 agent that has shown minimal cardiotoxicity in clinical trials. H
Externí odkaz:
https://doaj.org/article/032b82b4ff534829b0faa94dde68d70a
Autor:
Stephen D’Auria, Ahmet Sezer, Floyd Thoma, Michael Sharbaugh, Jeffrey McKibben, Robert Maholic, Efthymios D. Avgerinos, Belinda N. Rivera-Lebron, Catalin Toma
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Background Catheter-directed thrombolysis (CDL) is increasingly being used for the treatment of submassive and massive pulmonary embolism. Although this therapy has been shown to be effective at reducing right ventricle strain, the impact on clinical
Externí odkaz:
https://doaj.org/article/71428da35c274b778445f169538c35a6
Autor:
Ali Murat SEDEF, Fatih KÖSE, Ahmet Taner SÜMBÜL, Hüseyin MERTSOYLU, Ali Ayberk BESEN, Ahmet SEZER, Özgür ÖZYILKAN, Hüseyin ABALI
Publikováno v:
Cukurova Medical Journal, Vol 43, Iss 3, Pp 533-538 (2018)
Amaç: Nöroendokrin tümörler (NET) tümör ve hasta özellikleri, muhtemelen tüm dünyada çevresel ve genetik faktörlerin yol açtığı coğrafi alanlar arasında önemli değişiklik göstermektedir. Bu nedenle, tek merkez deneyimi bildirmek,
Externí odkaz:
https://doaj.org/article/2f71371094a1406c80128ab72730ba94
Autor:
Erkan Topkan, Huseyin Mertsoylu, Ahmet Kucuk, Ali Ayberk Besen, Ahmet Sezer, Duygu Sezen, Yasemin Bolukbasi, Ugur Selek, Berrin Pehlivan
Publikováno v:
Gastroenterology Research and Practice, Vol 2020 (2020)
Background. We investigated the prognostic significance of pretreatment systemic inflammation response index (SIRI) in locally advanced pancreatic carcinoma (LAPC) patients treated with concurrent chemoradiotherapy (CRT). Methods. Present retrospecti
Externí odkaz:
https://doaj.org/article/c7d2c5f78af04999aaeaa487e023879a